TheEdgeResearch
Home / Stocks / APLIF

Appili Therapeutics Inc. (APLIF)

OTC Healthcare Medical - Pharmaceuticals
$0.00 ▲ +0.00%
Market Cap
$132,366
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Beta
-0.21
52-Wk Range
0.001-0.02
CEO
Don Cilla
Country
CA
Currency
USD

Appili Therapeutics Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Halifax, NS, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $132,366. Its beta of -0.21 implies it has historically moved less than the broad market.

Company profile
Exchange
Other OTC
Employees
7
IPO date
2021-01-08
Headquarters
Halifax, NS, CA
About Appili Therapeutics Inc.

Appili Therapeutics, Inc. is a biopharmaceutical company, which engages in acquisition and development of novel treatments targeting unmet needs in infectious disease. It focuses on building and advancing a diverse portfolio of anti-infective programs such as LIKMEZ, ATI-1701 and ATI-1801. The company was founded on May 7, 2015 and is headquartered in Halifax, Canada.

Comparable companies

Appili Therapeutics Inc. is most often compared with the following Healthcare names:

AAGHADXSAGNPFHESGIBOGFIBXXFNMLSFRGBPRNUGFVGLS
More research on APLIF
APLIF technical analysis APLIF TheEdge Score Compare against peers
Open full interactive analysis & DCF →